Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Amortization - Intangibles (2019 - 2025)

Collegium Pharmaceutical (COLL) has 7 years of Amortization - Intangibles data on record, last reported at $55.5 million in Q3 2025.

  • For Q3 2025, Amortization - Intangibles rose 35.96% year-over-year to $55.5 million; the TTM value through Sep 2025 reached $221.9 million, up 53.72%, while the annual FY2024 figure was $55.5 million, 61.94% down from the prior year.
  • Amortization - Intangibles reached $55.5 million in Q3 2025 per COLL's latest filing, roughly flat from $55.5 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $55.5 million in Q1 2025 and bottomed at $16.8 million in Q1 2021.
  • Average Amortization - Intangibles over 5 years is $35.8 million, with a median of $37.5 million recorded in 2023.
  • Peak YoY movement for Amortization - Intangibles: skyrocketed 151.74% in 2022, then dropped 18.37% in 2023.
  • A 5-year view of Amortization - Intangibles shows it stood at $16.8 million in 2021, then surged by 151.74% to $42.3 million in 2022, then fell by 18.37% to $34.5 million in 2023, then surged by 60.72% to $55.5 million in 2024, then grew by 0.0% to $55.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization - Intangibles were $55.5 million in Q3 2025, $55.5 million in Q2 2025, and $55.5 million in Q1 2025.